Literature DB >> 25446027

Synthesis, anticonvulsant activity and metabolism of 4-chlor-3-methylphenoxyethylamine derivatives of trans-2-aminocyclohexan-1-ol.

Paulina Kubowicz1, Henryk Marona, Elżbieta Pękala.   

Abstract

In this study, we report the synthesis, spectral characterization, antiepileptic activity and biotransformation of three new, chiral, N-aminoalkyl derivatives of trans - 2 aminocyclohexan-1-ol: (R enantiomer), (S enantiomer) and (racemate). Antiepileptic activity of the titled compounds was studied using MES and scMet. Moreover, in this study, the biotransformation of , and in microbial model (Cunninghamella), liver microsomal assay as well as in silico studies (MetaSite) was evaluated. Studies have indicated that , and have good antiepileptic activity in vivo, comparable to valproate. Biotransformation assays showed that the most probable metabolite (indicated in every tested assays) was . The microbial model as well as in silico study showed no difference in biotransformation between tested enantiomers. However, in a rat liver microsomal study compound and (R and S enantiomer) had different main metabolite - for and for . MS/MS fragmentation allowed us to predict the structures of obtained metabolites, which were in agreement with 1°alcohol () and carboxylic acid (). Our research has shown that microbial model, microsomal assay, and computational methods can be included as useful and reliable tools in early ADME-Tox assays in the process of developing new drug candidates.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Anticonvulsant activity; Biotransformation; Cunninghamella; Enantiomers; Liver microsomes

Mesh:

Substances:

Year:  2014        PMID: 25446027     DOI: 10.1002/chir.22406

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  1 in total

1.  Asymmetric Amination of meso-Epoxide with Vegetable Powder as a Low-Toxicity Catalyst.

Authors:  Yuki Takeuchi; Tatsuhiro Asano; Kazuya Tsuzaki; Koichi Wada; Hiroyuki Kurata
Journal:  Molecules       Date:  2020-07-13       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.